The Anticancer Mechanism of the Ribonucleotide Reductase Inhibiting Drug COH29 Involves Suppression of DNA Repair. Homo sapiens
收藏NIAID Data Ecosystem2026-03-08 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA238227
下载链接
链接失效反馈官方服务：
资源简介：
Mechanism of Action Study for COH29 Overall design: Compare COH29 treatment in DNA-repair deficient cell line with truncated BRCA1 (HCC1937) versus phenotypically normal cell line with exogenous WT BRCA1 expression (HCC1937+BRCA1)
创建时间：
2014-02-13
